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The nuclear lamins are essential for variousmolecular
events in thenucleus, suchaschromatin organization,
DNA replication, andprovisionofmechanical support.
A specific point mutation in the LMNA gene creates a
truncatedprelaminA termedprogerin, causingHutch-
inson-Gilford progeria syndrome (HGPS). SIRT6 defi-
ciency leads to defective genomic maintenance and
accelerated aging similar to HGPS, suggesting a po-
tential linkbetween laminAandSIRT6.Here,we report
that lamin A is an endogenous activator of SIRT6
and facilitates chromatin localization of SIRT6 upon
DNA damage. Lamin A promotes SIRT6-dependent
DNA-PKcs (DNA-PK catalytic subunit) recruitment to
chromatin, CtIP deacetylation, and PARP1 mono-
ADP ribosylation in response to DNA damage. The
presence of progerin jeopardizes SIRT6 activation
and compromises SIRT6-mediated molecular events
in response to DNA damage. These data reveal a
critical role for lamin A in regulating SIRT6 activities,
suggesting that defects in SIRT6 functions contribute
to impaired DNA repair and accelerated aging in
HGPS.
INTRODUCTION
In the past few years, there has been a significant advancement
in our understanding of SIRT6, one of the seven mammalian sir-
tuins with various catalytic activities (Giblin et al., 2014). SIRT6,
predominantly a nuclear protein (Michishita et al., 2005), has
been reported to catalyze both deacylation and mono-ADP ribo-
sylation (Gertler and Cohen, 2013). Although SIRT6 was initially
known to deacetylate histone H3 at lysine 9 and 56 both globally
and at specific gene loci (Michishita et al., 2008, 2009; Kawahara
et al., 2009), it was later identified to also deacetylate CtIP, a non-
histone protein mediating DNA end resection after DNA damage
(Kaidi et al., 2010). PARP1, an important protein in genomic
maintenance and aging (Mangerich and B€urkle, 2012), is a
known substrate of SIRT6 for mono-ADP ribosylation (Mao
et al., 2011). SIRT6 is also known to mediate its own mono-
ADP ribosylation (Liszt et al., 2005). Apart from PARP1, SIRT61396 Cell Reports 13, 1396–1406, November 17, 2015 ª2015 The Auhas been reported to mediate mono-ADP ribosylation of the nu-
clear corepressor Kap1, thereby aiding in the packaging of L1
retrotransposons into transcriptionally repressive heterochro-
matin (Van Meter et al., 2014). Recently, hydrolysis of long-chain
fatty acyl moieties from lysine residues has been described as
the third enzymatic activity of SIRT6 (Jiang et al., 2013). Several
independent studies have revealed and elucidated the roles of
SIRT6 in a spectrum of biological processes, such as DNA dam-
age repair, cellular metabolism, inflammation, cancer, and aging
(Kugel and Mostoslavsky, 2014). The in vivo biological functions
of SIRT6 have been well illustrated and appreciated through
studies in Sirt6 knockout mice. Loss of Sirt6 in mice leads to se-
vere signs of degenerative progeroid phenotypes, attributable to
the defects in DNA damage repair (Mostoslavsky et al., 2006).
Additionally, exogenous mammalian SIRT6 could extend life-
span in male, but not female, mice (Kanfi et al., 2012), further
supporting that SIRT6 is critical in regulating aging processes
and longevity. SIRT6 is known to mediate DNA double-strand
break (DSB) repair via homologous recombination (HR) and
non-homologous end-joining (NHEJ) repair pathways (Kaidi
et al., 2010; Mao et al., 2011). Overexpression of SIRT6 in human
fibroblasts stimulates HR repair and delays replicative senes-
cence (Mao et al., 2012). SIRT6 is also known to stabilize DNA-
PKcs (DNA-PK catalytic subunit) at DSB foci for the repair
process (McCord et al., 2009). In addition, SIRT6 has been re-
ported to be responsible for recruiting the chromatin remodeler
SNF2H to the DNA break sites and thus preventing genomic
instability (Toiber et al., 2013). These data suggest that SIRT6
contributes to aging processes and lifespan regulation largely
via its functions in the maintenance of genomic integrity (Van
Meter et al., 2011b). Apart from genome maintenance, SIRT6
also plays crucial roles in tumor suppression (Sebastia´n et al.,
2012; Min et al., 2012; Van Meter et al., 2011a) and metabolic
regulation (Dominy et al., 2012, Elhanati et al., 2013). Although
SIRT6 has been implicated in a plethora of cellular functions,
the regulation of its activity in DNA damage repair remains largely
elusive, and no endogenous modulator has been reported so far
(Gertler and Cohen, 2013).
The nuclear lamins, together with their interacting partners,
form a complex meshwork of proteins to provide mechanical
support to the nuclear envelope and maintain proper chromatin
organization and transcriptional regulation (Luperchio et al.,
2014). They act as a bridge between the inner nuclear membrane
and chromatin (Ciska and Moreno Dı´az de la Espina, 2014; Kindthors
Figure 1. Lamin A Directly Interacts with SIRT6
(A) Lamin A and FLAG-SIRT6 were ectopically expressed in HEK293 cells, and
co-immunoprecipitation was done using FLAG antibodies. Western blotting
shows the presence of lamin A in anti-FLAG immunoprecipitates only from
samples overexpressing FLAG-SIRT6. IP stands for immunoprecipitated
samples.
(B) FLAG-lamin A and empty vector (EV) were ectopically expressed in
HEK293 cells. By western blotting analysis, SIRT6 could be detected in anti-
FLAG immunoprecipitates from the sample containing FLAG-lamin A.
(C) Western blotting showing that endogenous SIRT6 could be pulled down
from whole-cell lysates of HEK293 cells by lamin A antibodies.
(D) Recombinant human SIRT6 (rhSIRT6, 2 mg) was co-immunoprecipitated
with recombinant lamin A (rhlamin A, 2 mg) in test tubes using antibodies
against lamin A.
See also Figures S1 and S6.and van Steensel, 2010). The LMNA gene gives rise to four types
of A-type lamins via alternative splicing, with lamin A and lamin C
being the two most predominant species found in mammals and
lamin AD10 and lamin C2 being the less expressed ones (Cau
et al., 2014). Mutations in the LMNA gene lead to a variety of dis-
orders in humans, collectively called laminopathies (Schreiber
and Kennedy, 2013). A de novo single base substitution from C
to T at position 1,824 in LMNA gene exposes a cryptic splicing
site and gives rise to truncated prelamin A, termed as progerin,
with a 50-amino-acid deletion at the C terminus (Eriksson
et al., 2003), leading to Hutchinson-Gilford progeria syndrome
(HGPS), a severe form of early-onset premature aging disorder
(Liu and Zhou, 2008). Progeroid cells are characterized by
morphological abnormality, misshaped nucleus, heterochro-
matin loss, delayed DNA damage response, and mislocalization
of nuclear proteins (Prokocimer et al., 2013; Krishnan et al.,
2011).
Sirt6/ mice exhibit several progeroid phenotypes such as
reduced body size and weight, acute degenerative phenotypes,
loss of subcutaneous fat, osteopenia, and failure to thrive as well
as severe metabolic defects, many of which resemble the
chronic abnormalities found in HGPS patients such as extremeCell Repshort stature, loss of body weight, lipodystrophy, osteolysis,
and early mortality at a mean age of 13 years (Mostoslavsky
et al., 2006; Hennekam, 2006). Similar to HGPS cells, Sirt6/
cells display severe impairment in DNA damage repair and pre-
mature senescence. However, alopecia, which is characteristic
of nearly all HGPS patients, is not so evident in Sirt6/ mice
(Mostoslavsky et al., 2006; Musich and Zou, 2011). We have
recently reported that lamin A acts as an activator of SIRT1
(Liu et al., 2012). Given that loss of Sirt6 results in compromised
genomic maintenance and Sirt6/ mice recapitulate many of
the progeroid phenotypes found in HGPS, it is plausible that
there might be a functional link between SIRT6 activities and
lamin A. In the present study, we show that lamin A directly inter-
acts with SIRT6 and promotes SIRT6-mediated histone deacety-
lation. Lamin A also facilitates SIRT6-mediated events in DSB
repair. On the other hand, progerin exhibits a striking impairment
in stimulating SIRT6 activities. The functions of SIRT6 in HGPS
fibroblasts are significantly compromised in response to DNA
damage, indicating impaired SIRT6 activities as a contributing
underlying mechanism in HGPS.
RESULTS
Lamin A Directly Interacts with SIRT6
To identify the potential role of lamin A in the regulation of SIRT6
functions, we first examined the interaction between the two pro-
teins. We ectopically expressed FLAG-SIRT6 and lamin A in
HEK293 cells and pulled down SIRT6 by FLAG antibodies. As
shown in Figure 1A, lamin A was observed in the anti-FLAG
immunoprecipitates. Reciprocally, SIRT6 was pulled down
together with FLAG-lamin A by anti-FLAG antibodies in
HEK293 cells (Figure 1B). To further confirm this observation,
we examined their endogenous interaction. As shown in Figures
1C and S6A, antibodies against lamin A could successfully pull
down SIRT6 in HEK293 cells. Similar results were also observed
in mouse embryonic fibroblasts (MEFs), and no Sirt6 was pulled
down by lamin A antibodies inMEFs lacking lamin A (Figure S1A).
This is in accordance with the proteomic studies performed
using mass spectrometry analyses stating potential interaction
between SIRT6 and lamin A (Simeoni et al., 2013; Miteva and
Cristea, 2014). To further analyze whether lamin A is in direct
physical association with SIRT6, we performed a co-immuno-
precipitation assay using recombinant proteins (rhSIRT6 and
rhlamin A, 2 mg of each) in vitro. As shown in Figure 1D, lamin
A could pull down SIRT6 in vitro. Taken together, these data
demonstrate that lamin A can directly interact with SIRT6.
The Core Domain of SIRT6 Is Crucial for Its Interaction
with Lamin A
The different domains of SIRT6 have been reported to be
involved in several independent as well as interdependent func-
tions (Tennen et al., 2010). The N-terminal extension is crucial for
its catalytic activity and chromatin association, while the C-ter-
minal extension is required for its proper nuclear localization.
Interestingly, a point mutation in the catalytic core domain of
SIRT6 impairs not only the catalytic activity but also its associa-
tion with chromatin (Tennen et al., 2010). To understand which
domain of SIRT6 is responsible for binding with lamin A, weorts 13, 1396–1406, November 17, 2015 ª2015 The Authors 1397
Figure 2. The Core Domain of SIRT6 Is
Crucial for Its Interaction with Lamin A
(A) FLAG-tagged full-length and different-domain-
deleted mutants of SIRT6 (diagrammatically rep-
resented on the right) were transiently expressed
in HEK293 cells and co-immunoprecipitated by
antibodies against lamin A. Western blotting was
performed using FLAG antibodies. Lamin A/C
western blotting served as internal control.
(B) FLAG-tagged wild-type SIRT6 and its catalytic
mutant H133Y (containing a point mutation in its
catalytic core domain) were ectopically expressed
in HEK293 cells and co-immunoprecipitated by
lamin A. Western blotting was performed using
FLAG antibodies. Data are from three independent
experiments; **p < 0.01.
(C) Equal amounts of lamin A, progerin, and lamin
C DNA constructs (5 mg each) were transiently
expressed in HEK293 cells along with FLAG-
SIRT6 (5 mg) and co-precipitated by FLAG anti-
bodies. Western blotting was performed using
lamin A antibodies that recognize lamins A and C
and progerin.
(D) Equal amount of FLAG-tagged sirtuin 1, 2, 5, 6,
and 7 constructs (10 mg) were ectopically ex-
pressed in HEK293 cells and immunoprecipitated
by FLAG antibodies. SIRT1, 2, 6, and 7 displayed
clear interaction with lamin A, while SIRT5 ex-
hibited no detectable binding in the western blot-
ting. EV stands for empty vector.
See also Figures S1 and S6.examined the interaction of SIRT6 with lamin A using SIRT6 mu-
tants with different domain deletions. As shown in Figures 2A
and S6B, all SIRT6 mutants containing catalytic core domain
could be pulled down by endogenous lamin A in HEK293 cells.
The NTE domain (N-terminal extension) of SIRT6 was hardly
detectable despite several trials whereas the CTE (C-terminal
extension) domain could not be pulled down by lamin A anti-
bodies (last lane in Figure 2A), even though an appreciable
expression could be observed in the input. This suggests that
lamin A interacts with SIRT6 via the catalytic core domain of
SIRT6. Interestingly, the binding of lamin A with SIRT6 catalytic
pointmutant (SIRT6H133Y)was significantly reduced (Figure 2B;
n = 3, **p < 0.01), indicating that the conformation of catalytic
core domain of SIRT6 is crucial for its binding with lamin A.
Lamins A and C and progerin share an identical N-terminal re-
gion and vary from each other only in their C terminus, as dia-
grammatically represented in Figure S1C. To analyze the region
of lamin A involved in the interaction with SIRT6, we ectopically
expressed FLAG-SIRT6 along with lamin A, progerin and lamin
C in HEK293 cells. As shown in Figure 2C, while lamin A and pro-
gerin could be observed in the anti-FLAG immunoprecipitates,
lamin C pull-down was hardly detectable even after overexpres-
sion, suggesting that the N terminus of lamin A is dispensable
for this interaction to take place and the C terminus dictates
binding to SIRT6. However, upon prolonged exposure, a faint
band of lamin C was detectable in the anti-FLAG immunoprecip-
itates (data not shown), which is likely due to indirect interaction
given the existence of lamin A and lamin C in a complex (Luo
et al., 2014). The existence of prelamin A in lamin A expressing
cells is likely a consequence of saturated activity of prelamin A1398 Cell Reports 13, 1396–1406, November 17, 2015 ª2015 The Auprocessing enzyme(s) due to large amount of lamin A precursor
expression, since plasmids expressing full-length cDNA of
LMNA gene have been used in the study (Figure 2C). To narrow
down the C-terminal amino acids of lamin A binding with SIRT6,
we synthesized three peptides containing fragments from the
C-terminal domain of lamin A (schematically represented in Fig-
ure S1D). We biotinylated the peptides, followed by incubation
with recombinant SIRT6, and then performed pull-down by using
Streptavidin beads. As shown in the silver staining (Figure S1D),
peptide 1 (containing the last 80 amino acids of lamin A) and pep-
tide 2 (containing the 30 amino acids common to both lamin A
and progerin), but not peptide 3, could pull down SIRT6. This
suggests that the 30 amino acids common to both lamin A and
progerin are crucial for interacting with SIRT6. We also tested
the potential interaction between lamin A and different sirtuins
by co-immunoprecipitation in HEK293 cells expressing FLAG-
tagged sirtuins and observed clear interaction of lamin A with
SIRT1, 2, 6, and 7 (Figure 2D). However, mitochondrial SIRT5
showed no detectable interaction. To confirm this observation,
the interactions between lamin A and different sirtuins were
examined by pulling down endogenous lamin A (Figures S1B
and S6C). Again, lamin A was found to interact with nuclear sir-
tuins. No interaction was detected between lamin A and mito-
chondrial sirtuin SIRT5 (Figures S1B and S6C).
Lamin A, but Not Progerin, Enhances SIRT6Deacetylase
Activity
The immediate question following these observations is what the
biological relevance of the interaction is. SIRT6 has been re-
ported to be responsible for deacetylation of histone H3 at lysinethors
Figure 3. Lamin A, but Not Progerin, Enhances SIRT6 Deacetylase Activity
(A) SIRT6 and lamin A were ectopically expressed in HEK293 cells, either individually or in combination. Western blotting was performed in whole-cell lysates
collected 48 hr posttransfection. The quantification represents mean ± SEM relative to non-transfected control (n = 3). *p < 0.05, **p < 0.01. LA and S6 stand for
lamin A and SIRT6, respectively.
(B) Acid-extracted histones (2 mg) were incubated with recombinant SIRT6 (rhSIRT6, 1 mM) in the presence or absence of increasing concentrations of re-
combinant lamin A (rhlamin A). The concentrations of rhlamin A used were 0.2 mM, 0.3 mM, and 0.5 mM, respectively. Western blotting was performed to examine
the acetylation level of H3K9. The graph shows quantification of data with respect to control (i.e., histones only) and representsmean ±SEM (n = 3). *p < 0.05. Nico
stands for nicotinamide.
(C) An equal amount of either lamin A or progerin construct (5 mg each) was transiently expressed in HEK293 cells either alone or alongwith SIRT6 construct (5 mg).
Western blotting was performed with whole-cell extract collected 48 hr after transfection to examine levels of H3K9 and H3K56 acetylation.
(D) In vitro deacetylation assay was performed using acid extracted histones (2 mg, the substrate for SIRT6) and recombinant SIRT6 (1 mM) in the presence of
either recombinant lamin A (0.5 mM) or recombinant progerin (0.5 mM). Western blotting was performed to examine the acetylation of H3K9 and H3K56. The
quantification, all relative to control (i.e., histones only), represents mean ± SEM (n = 3). *p < 0.05.
See also Figures S2 and S6.9 and 56 (Michishita et al., 2008, 2009; McCord et al., 2009).
Hence, we decided to test whether lamin A could regulate
SIRT6 deacetylase activity by analyzing the acetylation levels
of H3K9 and H3K56 in HEK293 cells with ectopic expression
of lamin A and SIRT6. As shown in Figures 3A and S6D, ectopic
lamin A alone did not have any significant effect, possibly due to
saturation of SIRT6 activity by the endogenous lamin A. As ex-
pected, the acetylation of histone H3 at lysine 9 and 56 was
significantly reduced upon ectopic expression of SIRT6. Inter-
estingly, a further reduction in H3K9 and H3K56 acetylation
was observed in cells with both ectopic lamin A and ectopic
SIRT6, as compared to that with ectopic SIRT6 alone (n = 3,
*p < 0.05, **p < 0.01). As a negative control, we also examined
the acetylation levels of histone H3 at lysine 18, which is not a
target of SIRT6. No detectable changes in H3K18 acetylation
were observed in cells either with ectopic SIRT6 alone or
with SIRT6 and lamin A together (Figure S2A). To test if the
enhanced histone deacetylation by lamin A is SIRT6 deacetylaseCell Repspecific, SIRT6H133Ymutant was employed to see if the deace-
tylase inactivation would abolish the increased histone H3K9 de-
acetylation. As shown in Figure S2B, no significant change in
H3K9 acetylation level was observed in cells with ectopic
SIRT6 H133Y mutant in the presence or absence of ectopic
lamin A. This suggests that the deacetylation of histones is
SIRT6 specific and further reduction of acetylation in the pres-
ence of lamin A and SIRT6 is also SIRT6 specific. Loss of lamin
A in MEF cells (Lmna/MEFs) also resulted in increased acety-
lation of H3K9 and H3K56, but not H3K18, in comparison with
wild-type (WT) MEFs (Figure S2C), thus further advocating the
essence of lamin A in SIRT6-mediated histone deacetylation.
Since lamin A could affect the function of other sirtuins, we per-
formed in vitro deacetylation assay using acid extracted his-
tones, recombinant SIRT6 (rhSIRT6, 1 mM), and recombinant
lamin A (rhlamin A, with varying concentrations of 0.2, 0.3, and
0.5 mM) proteins, to further examine whether lamin A-mediated
enhancement in histone deacetylation is SIRT6 specific. Asorts 13, 1396–1406, November 17, 2015 ª2015 The Authors 1399
Figure 4. Lamin A Is Required for Efficient Chromatin Localization of SIRT6 upon DNA Damage
(A) HEK293 cells were transiently transfected with either siRNA against lamin A or scramble siRNA. Cell lysates were collected and fractionated as described in
chromatin purification protocol (see Experimental Procedures) before and after 10 Gy gamma irradiation. SIRT6 level was determined by western blotting in
different fractions. Dt, detergent-extractable portion; Rn, RNase-extractable portion; Chr, purified chromatin portion. Bar graphs show quantified data, with
respect to corresponding non-irradiated controls, and represent mean ± SEM (n = 3) (SIRT6, uppermost panel; DNA-PKcs, lowermost panel). *p < 0.05. NC, NO
IR, and siLA stand for negative control, no irradiation, and siRNA against lamin A, respectively.
(B) Wild-type (WT) mouse embryonic fibroblasts (MEFs) and Lmna/ (LA/) MEFs were treated with 10 Gy gamma irradiation. Cell lysates were fractionated to
determine Sirt6 levels. Dt, detergent-extractable portion; Rn, RNase-extractable portion; Chr, purified chromatin portion. Bar graphs show quantified data (SIRT6
for the uppermost panel), with respect to corresponding non-irradiated controls, representing mean ± SEM (n = 3). *p < 0.05.
(C) 10 mg of either lamin A or progerin was ectopically expressed in HEK293 cells with 10 Gy gamma irradiation. Cell lysates were fractionated to determine Sirt6
levels by western blotting. Dt, detergent-extractable portion; Rn, RNase-extractable portion; Chr, purified chromatin portion. Two independent experiments were
performed and similar data were obtained.
See also Figure S2.shown in Figure 3B, SIRT6-mediated H3K9 deacetylation could
be enhanced by lamin A in vitro (three independent experi-
ments, *p < 0.05), suggesting that lamin A could directly acti-
vate SIRT6 toward histone deacetylation. Although progerin
exhibited stronger binding with SIRT6 (Figures 2C and S2D),
it had a negligible effect on the deacetylase activity of SIRT6
on histones H3K9 and H3K56 after ectopic expression in
HEK293 cells (Figure 3C). This observation was confirmed in
the in vitro deacetylation assay, as evidenced by the compara-
ble levels of both H3K9 and H3K56 acetylation in the presence
and absence of progerin (Figure 3D) (data from three indepen-
dent experiments; *p < 0.05). Enhanced binding but diminished
activating effect of progerin further prompted us to investigate
whether progerin could activate SIRT6 with increasing concen-
tration. As shown in Figure S2E, increasing concentration of
progerin (0.2 mM, 0.3 mM, and 0.5 mM) did not result in
enhanced deacetylase activity of SIRT6 toward H3K9 in vitro.
Taken together, these data indicate that while both lamin A
and progerin interact directly with SIRT6, lamin A, but not pro-
gerin, is able to enhance SIRT6 deacetylase activity toward
H3K9 and H3K56.1400 Cell Reports 13, 1396–1406, November 17, 2015 ª2015 The AuLamin A Enhances Efficient Chromatin Localization of
SIRT6 upon DNA Damage
It is reported that enhanced localization of SIRT6 to chromatin
upon DNA damage facilitates DNA damage repair (DDR)
signaling (McCord et al., 2009). However, the molecular mecha-
nism regulating this localization remains largely unknown. To test
if lamin Amay play a role in the regulation of SIRT6 recruitment to
chromatin upon DNA damage, we examined gamma irradiation
(IR) induced-chromatin enrichment of SIRT6 in HEK293 cells
where lamin A was knocked down by small interfering RNA
(siRNA) (Figure S2F). We followed a stringent chromatin fraction-
ation protocol to obtain purified chromatin-bound proteins as
previously described by Drouet et al. (2005) and McCord et al.
(2009) (as seen from the enrichment of histones only in the chro-
matin-bound fraction). The protocol allowed for extraction of
detergent-extractable soluble nuclear and cytoplasmic frag-
ment, followed by RNase-extractable fragment, and finally the
chromatin-associated proteins. As shown in Figure 4A, the
enrichment of SIRT6 on chromatin after DNA damage (3rd and
6th lanes) was abolished upon lamin A knockdown (9th and 12th
lanes) (data from three independent experiments, *p < 0.05).thors
To exclude the possibility that compromised chromatin enrich-
ment of SIRT6 upon IR in lamin A knockdown cells may be the
result of an off-target effect, we examined SIRT6 recruitment
to chromatin in Lmna/ MEFs. As shown in Figure 4B,
compared to WT MEFs, loss of lamin A significantly compro-
mised the enrichment of Sirt6 to chromatin in response to DNA
damage (data from three independent experiments, *p < 0.05).
Intriguingly, SIRT6 localization to chromatin could be observed
even in absence of lamin A, thus suggesting the presence of
other regulatory factors that aid in the basal level of SIRT6
recruitment to chromatin. Notably, no obvious changes in the to-
tal SIRT6 levels were observed in either lamin A knockdown or
lamin A-depleted cells as compared with controls (Figures S2F
and S2G). In addition, no apparent induction in the total level
of SIRT6 protein was observed 30 min postirradiation (Figures
S2F and S2G). Similarly, neither ectopic lamin A nor ectopic pro-
gerin resulted in significant changes in the total level of SIRT6
(Figure S2H). However, HEK293 cells expressing ectopic pro-
gerin exhibited impaired SIRT6 enrichment in chromatin upon
DNA damage, in comparison with cells expressing ectopic lamin
A (Figures 4C and S2I). To further substantiate this observation,
the recruitment of DNA-PKcs to chromatin upon DNA damage
was examined, as SIRT6 on chromatin facilitates DNA-PKcs
recruitment (McCord et al., 2009). As expected and consistent
with defective SIRT6 enrichment, DNA-PKcs localization to
chromatin upon irradiation was significantly compromised in
HEK293 cells when lamin A was knocked down (Figure 4A)
(data from three independent experiments, *p < 0.05). Unfortu-
nately, the mobilization of DNA-PKcs to chromatin in Lmna/
MEFs could not be detected due to the inability of the antibodies
to recognize mouse DNA-PKcs. Taken together, these data sug-
gest that efficient recruitment of SIRT6 onto chromatin upon
DNA damage requires lamin A and loss of lamin A or the pres-
ence of progerin compromises the recruitment of SIRT6 to chro-
matin in response to DNA damage.
Lamin A Promotes SIRT6-Mediated DNA Repair
SIRT6 plays a vital role in DNA DSB repair (Etchegaray et al.,
2013; Beauharnois et al., 2013). For example, SIRT6 mediates
HR repair via NAD+-dependent CtIP deacetylation (Kaidi et al.,
2010). Our previous study showed that a progeroid mutation in
the LMNA gene jeopardizes HR repair, which contributes to
HGPS (Liu et al., 2005). Interestingly, loss of Sirt6 in mice results
in defective DNA repair and accelerated aging similar to that in
HGPS, suggesting a potential link between lamin A and SIRT6
in DNA repair and accelerated aging. Moreover, a recent study
showed striking defects in HR and NHEJ repair pathways in cells
lacking lamin A/C (Redwood et al., 2011). We therefore hypoth-
esized that lamin A might play a role in promoting SIRT6-medi-
ated DSB repair and the defects observed in cells lacking lamin
A/C might result from dysregulated SIRT6 function. Thus, to
investigate possible role of lamin A in SIRT6-mediated DNA
repair, we examined whether lamin A is required for SIRT6-medi-
ated deacetylation of CtIP upon DNA damage. As shown in
Figure 5A, acetylated CtIP was decreased 10 min after DNA
damage in WT MEFs, whereas this CtIP deacetylation immedi-
ately after DNA damage was not observed in MEFs lacking lamin
A (data from three independent experiments, *p < 0.05). EctopicCell Replamin A in HEK293 cells further enhanced CtIP deacetylation
upon DNA damage (Figure S3A). However, such an activating
effect of lamin A overexpression was abolished after knocking
down SIRT6 using small hairpin RNA (shRNA) (Figure S3A).
Moreover, progerin overexpression attenuated the basal
SIRT6-mediated CtIP deacetylation (Figure S3A), thus suggest-
ing a possible dominant-negative role of progerin in regulating
SIRT6 functions. Compared with WT MEFs, the increased asso-
ciation of CtIP with SIRT6 was significantly compromised in
Lmna/ MEFs 30 min after DNA damage (Figure 5B). This sug-
gests that delayed SIRT6 recruitment to chromatin due to loss of
lamin A leads to decreased CtIP recruitment and hence attenu-
ated CtIP deacetylation. In line with this, reconstitution of lamin
A in Lmna/ MEFs enhanced CtIP deacetylation in Lmna/
MEFs 30 min after IR, whereas progerin reconstitution in
Lmna/ MEFs exhibited no dramatic effect on CtIP deacetyla-
tion in response to IR (Figure 5C) (data from three independent
experiments, *p < 0.05). Given SIRT6 is the only known deacety-
lase for CtIP (Kaidi et al., 2010), the observation that knocking
down Sirt6 attenuated lamin A-mediated enhanced deacetyla-
tion of CtIP upon DNA damage (Figures S3A and S3B) further
confirmed that lamin A-mediated enhancement of CtIP deacety-
lation is SIRT6 dependent. Again, ectopic expression of progerin
did not result in further reduction of CtIP acetylation in Lmna/
MEFs upon DNA damage (Figure S3B). These data therefore
suggest that lamin A facilitates SIRT6-mediated CtIP deacetyla-
tion in response to DNA damage. On the other hand, progerin
compromises SIRT6-mediated CtIP deacetylation upon DNA
damage.
To further substantiate the finding that lamin A is an endoge-
nous activator of SIRT6 and facilitates SIRT6-mediated DNA
repair, we examined PARP1 mono-ADP ribosylation, a SIRT6-
mediated event that has been rendered crucial for the NHEJ
pathway of DSB repair (Mao et al., 2011). The mono-ADP ribosy-
lation imparts PARP1 a slightly higher molecular weight detect-
able in SDS-PAGE (Mao et al., 2011). We exploited this property
to investigate whether lamin A influences SIRT6-mediated
PARP1 mono-ADP ribosylation. As shown in Figures 5D and
S6E, the increase in SIRT6-mediated PARP1 mono-ADP ribosy-
lation in WTMEFs upon DNA damage was abolished in Lmna/
MEFs, as evidenced by the higher molecular weight of PARP1 in
the SIRT6 immunoprecipitates than in the input (data from three
independent experiments, *p < 0.05). Reconstitution with lamin
A, but not progerin, intoLmna/MEFs restoredSIRT6-mediated
PARP1mono-ADP ribosylation in response toDNAdamage (Fig-
ure 5E). We also performed neutral comet assay (as previously
described in Olive and Bana´th, 2006) on WT and Lmna/
(LA/) MEFs after SIRT6 overexpression to determine any
possible effect on DNA DSB repair in response to DNA damage.
As shown in Figures S3D and S3E, comet tail moments
were significantly reduced in WT MEFs after SIRT6 overexpres-
sion upon IR (data from three independent experiments, *p <
0.05, **p < 0.005), thus indicating fewer DNA DSBs. However,
this dramatic effect upon SIRT6 overexpression was severely
compromised in Lmna/ MEFs, thus suggesting that SIRT6-
mediated DNA damage repair is regulated by lamin A (Figures
S3D and S3E). Taken together, these findings signify lamin A as
an endogenous activator of SIRT6, regulating both deacetylationorts 13, 1396–1406, November 17, 2015 ª2015 The Authors 1401
Figure 5. Lamin A Promotes SIRT6-Mediated DNA Repair
(A) Acetylation of CtIP in response to 10 Gy gamma irradiation in wild-type (WT) and Lmna/ (LA/) MEFs. CtIP was immunoprecipitated before and after
irradiation. Total and acetylated CtIP were determined by western blotting. Graph shows quantified data, relative to corresponding non-irradiated control,
representing mean ± SEM (n = 3). *p < 0.05.
(B) Endogenous CtIP was co-immunoprecipitated using SIRT6 antibodies in wild-type and Lmna/ MEFs 30 min post gamma irradiation (10 Gy). Western
blotting shows levels of CtIP pulled down by SIRT6.
(C) Lmna/MEFs were reconstituted with either lamin A or progerin to determine the acetylation of endogenous CtIP in response to DNA damage (10 Gy gamma
irradiation). Cell extracts were collected 30min postirradiation. Western blotting was performedwith total cell lysates and immunoprecipitated CtIP. Graph shows
quantified data, relative to empty vector transfected non-irradiated control, representing mean ± SEM (n = 3). *p < 0.05.
(D)Western blotting to determine SIRT6-mediated PARP1mono-ADP ribosylation. PARP1was pulled down by SIRT6 antibodies to determine PARP1mono-ADP
ribosylation in response to 8 Gy gamma irradiation. Western blotting shows PARP1 protein levels in the input and immunoprecipitated samples in wild-type and
Lmna/MEFs before and after irradiation. Note that PARP1 in the co-immunoprecipitated sample is mono-ADP ribosylated. Graph shows quantified data with
respect to corresponding non-irradiated controls, and data represent mean ± SEM (n = 3). *p < 0.05.
(E) Lmna/MEFswere reconstituted with either lamin A or progerin to analyze SIRT6-mediated PARP1mono-ADP ribosylation upon DNA damage (8 Gy gamma
irradiation). Cell lysates were collected 2 hr after irradiation, immunoprecipitated with SIRT6 antibodies, and subjected to western blotting to determine mono-
ADP-ribosylated PARP1 levels in IP samples.
See also Figures S3 and S6.and mono-ADP ribosylation activities of SIRT6, thus facilitating
SIRT6-mediated DNA DSB repair upon DNA damage.
Since SIRT6 could be regulated by lamin A, we investigated if
lamin A was also a substrate of SIRT6 for deacetylation or mono-
ADP ribosylation. To address this, we immunoprecipitated lamin
A from sirt6+/+ and sirt6/MEFs and performedwestern blotting
using antibodies against acetylated lysine residues. As shown in
Figure S3F, lamin A was not detected by antibodies against
acetylated lysine.We also performed in vitro deacetylation assay
using recombinant proteins (rhSIRT6 and rhlamin A) but could
not detect any acetylation of lamin A (Figure S3G). In addition,
we performed in vitro mono-ADP ribosylation assay to test if
lamin A could be ADP ribosylated by SIRT6. We employed
rhSIRT6 and rhlamin A in the assay and included rhPARP1 as a1402 Cell Reports 13, 1396–1406, November 17, 2015 ª2015 The Aupositive control. As shown in Figure S3H, PARP1, but not lamin
A, was mono-ADP ribosylated by SIRT6 as determined by
SIRT6-mediated transfer of radiolabeled ADP-ribose moieties
to PARP1. These data suggest that lamin A is unlikely to be a
substrate of SIRT6.
As progerin is attached to the inner nuclear membrane (INM)
and is responsible for disruption of lamin-heterochromatin bind-
ing (Goldman et al., 2004; McCord et al., 2013), we hypothesized
that increased interaction between progerin and SIRT6 may
restrict the access and availability of SIRT6 to the chromatin,
where it plays crucial roles in response to DNA damage. To
test this, we fractionated HEK293 cells after ectopic expression
of lamin A or progerin and analyzed the localization of SIRT6 in
different subcellular fractions. As shown in Figure S3C, progerinthors
Figure 6. Defective SIRT6 Functions in HGPS
(A) Acetylation of CtIP in normal human dermal fibroblasts (F2-S) and fibroblasts derived fromHGPS patients (HG003) in response to DNA damage (10 Gy gamma
irradiation) analyzed by western blotting. Immunoprecipitated CtIP was probed with anti-acetyl lysine antibodies. Quantified data represent mean ± SEM (n = 3)
relative to corresponding non-irradiated controls. *p < 0.05.
(B) Levels of SIRT6-mediated PARP1 mono-ADP ribosylation in F2-S and HG003 fibroblast cells in response to DNA damage (8 Gy gamma irradiation).
Endogenous SIRT6 was immunoprecipitated by specific antibodies and SIRT6 interacting mono-ADP ribosylated PARP1 was detected by western blotting.
Quantified data represent mean ± SEM (n = 3). *p < 0.05 relative to corresponding non-irradiated controls.
(C) Localization of SIRT6 on chromatin in F2-S fibroblasts and HGPS fibroblasts upon DNA damage (10 Gy gamma irradiation). Cell lysates were fractionated to
determine SIRT6 levels by western blotting. Dt, detergent-extractable portion; Rn, RNase-extractable portion; Chr, purified chromatin portion. Bar graph shows
quantified data of SIRT6 relative to corresponding non-irradiated controls, representing mean ± SEM (n = 3). *p < 0.05.
See also Figures S4–S6.overexpression resulted in increased SIRT6 retention in the pel-
let fraction (depicted by PE fraction) and reduced localization at
the chromatin fraction (depicted as ChrE fraction) as compared
to lamin A-overexpressing cells.
Defective SIRT6 Functions in HGPS
To further address the importance of lamin A as an endogenous
activator of SIRT6, we investigated whether the presence of pro-
gerin impacts SIRT6 functions in HGPS. Since HGPS fibroblasts
exhibit defective DNA damage repair (Liu et al., 2005), we
hypothesized that such defect might be resulted from dysfunc-
tional SIRT6-mediated CtIP deacetylation or PARP1 mono-
ADP ribosylation. To test this, we examined and compared these
functions of SIRT6 between HGPS dermal fibroblasts and
normal dermal fibroblasts, i.e., F2-S cells. Several lines of
HGPS fibroblasts were used for experimentation (Table S1). As
shown in Figure 6A, we observed a significant impairment of
CtIP deacetylation upon DNA damage in HGPS fibroblasts as
compared to F2-S cells (data from three independent experi-
ments, *p < 0.05). Similarly, impairment in CtIP deacetylation
upon DNA damage was observed in three other HGPS fibroblast
cell lines (Figure S4A). The increased SIRT6-PARP1 complex for-
mation in response to DNA damage was also abolished in
the HGPS fibroblasts (Figures 6B and S4B). In addition, the
increased chromatin localization of SIRT6 upon DNA damage
was hampered in HGPS fibroblasts (Figures 6C, S4C, andCell RepS6F), as compared with F2-S controls (data from three indepen-
dent experiments, *p < 0.05). Consistent with these, delayed
localization of SIRT6 to DNA damage foci (ɤ-H2AX foci) was
observed in HGPS cells as compared to that in WT controls (Fig-
ure S4D). Taken together, the data observed in HGPS cells
clearly showed defects in a multitude of SIRT6 activities that
are considered crucial in DNA DSB repair through HR and
NHEJ pathways. These findings suggest that impaired SIRT6
functions contribute to defective genomic maintenance and
accelerated aging in HGPS.
Since functioning of SIRT6 was found to be impaired in the
HGPS cells, we tested whether overexpression of SIRT6 could
rescue the abnormalities found in HGPS cells, such as distorted
nuclear morphology and impaired 53BP1 foci formation (Liu
et al., 2005). Overexpression of SIRT6 in two independent
HGPS cell lines did not result in any significant rescue of cellular
morphology (Figure S5A). Also, ectopic expression of SIRT6 was
unable to rescue the impaired foci formation of 53BP1 in the
HGPS cells, both before and after gamma IR-induced DNA dam-
age (Figure S5B).
DISCUSSION
With the emerging functions of SIRT6 in a range of biological pro-
cesses, there is increased interest in identifying its modulators
that could be employed in developing effective therapeuticsorts 13, 1396–1406, November 17, 2015 ª2015 The Authors 1403
(Beauharnois et al., 2013). Although several novel inhibitors of
SIRT6 have been identified (Parenti et al., 2014), potential endog-
enous activators of this histone deacetylase have not been re-
ported so far. A recent study claimed that long-chain fatty acids
stimulate SIRT6 activity (Feldman et al., 2013). However, no data
have been shown for any endogenous substrates. Here, we have
identified lamin A as a direct interacting partner and an endoge-
nous activator of SIRT6. Although progerin exhibited seemingly
stronger interaction with SIRT6, it did not result in significant
enhancement of SIRT6 activities. On the contrary, the presence
of progerin compromised SIRT6 chromatin localization and
SIRT6-dependent downstream events upon DNA damage.
This phenomenon is reminiscent of DBC1’s strong interaction
with SIRT1 only to inhibit its downstream functioning (Kim
et al., 2008). In line with the increased binding between progerin
and SIRT6, it is plausible that the observed tethering of SIRT6 to
nuclear skeleton by progerin jeopardizes SIRT6 mobilization to
chromatin upon DNA damage. In addition, the binding may
mask the enzyme from its substrates or alter its conformation
in a way that the enzymatic activities are compromised. Alterna-
tively, progerin’s interactionwith SIRT6might facilitate other pro-
tein complexes to bind to SIRT6 and impair its activity.
Sirt6-deficient mice exhibit severe defects such as extensive
lymphopenia, loss of subcutaneous fat, muscular dystrophy,
and genomic instability. However, no nuclear architectural de-
fects have been reported in the mutant MEF cells (Mostoslavsky
et al., 2006). Interestingly, several of those defects have been
also observed in lamin A-deficient mice. For example, Lmna/
mice have smaller lymphoid organs and exhibit serious defects
in lymphocyte development (Hale et al., 2010). Additionally, dys-
trophy of muscular fat and loss of white adipose tissues have
also been reported in the Lmna/ mice (Sullivan et al., 1999).
Above all, both Sirt6/ and Lmna/ mice develop normally at
birth, display growth retardation at 2–3 weeks of age, and
exhibit progeroid phenotypes (Mostoslavsky et al., 2006; Sulli-
van et al., 1999). Reduced lamin A expression has been associ-
ated with human ovarian cancer (Zhou et al., 2014) and breast
cancer (Wazir et al., 2013), whereas loss of SIRT6 was reported
to induce tumorigenesis (Sebastia´n et al., 2012). Thus, these ob-
servations also suggest a potential functional link between lamin
A and SIRT6.
DSBs are one of the most critical DNA lesions, and SIRT6 is
one of the earliest factors to localize to the damage foci and
regulate the repair process (Liu et al., 2014; Toiber et al.,
2013). SIRT6 is a weak deacetylase, and its association with nu-
cleosomes considerably decreases the levels of H3K9 and
H3K56 acetylation (Gil et al., 2013; Pan et al., 2011; Liszt et al.,
2005). In this study, we have provided evidence that lamin A ac-
tivates SIRT6 toward a variety of its substrates. However, we did
not observe any posttranslational modification of lamin A medi-
ated by SIRT6. Lamin A-dependent SIRT6 enrichment on chro-
matin upon DNA damage provides a mechanistic explanation
for similar defects observed in DNA repair in SIRT6-deficient
cells and HGPS cells. It is reported that HGPS patient-derived
cells contain both lamin A and progerin, but progerin exhibits a
dominant-negative effect resulting in impaired genomic stability
(Goldman et al., 2004; McCord et al., 2013). Indeed, ectopic
SIRT6 did not significantly restore nuclear architecture or DNA-1404 Cell Reports 13, 1396–1406, November 17, 2015 ª2015 The Audamage repair in current study. The existence of progerin also
jeopardizes the functioning of SIRT6 toward DNA damage repair.
Hence, overexpression of SIRT6 in the presence of progerin was
unable to significantly rescue the nuclear architectural abnormal-
ities in HGPS cells. However, we cannot exclude the possibility
that SIRT6-mediated DNA-damage repair may be partially
rescued in HGPS cells if much higher level of ectopic SIRT6 is
present.
Our data support a model wherein lamin A promotes recruit-
ment of SIRT6 to the chromatin in response to DNA damage
and facilitates SIRT6-dictated downstream events critical for
DNA damage repair. It is plausible that lamin A helps SIRT6 to
target its specific catalytic activities to different substrates on
chromatin. On the other hand, the inability of progerin to
augment chromatin localization of SIRT6 and its downstream
functioning upon DNA damage provides mechanistic explana-
tion not only for the compromised genomic maintenance in
HGPS but also for the similar phenotypes observed in laminop-
athy-based premature aging and in Sirt6-deficient mice. Hence,
defective SIRT6 localization to chromatin contributes to the de-
layed recruitment of checkpoint response/damage repair pro-
teins in HGPS cells in response to DNA damage, leading to
defective DSB repair pathways, thus partly explaining the
genomic instability observed in the HGPS cells.
Given the momentous roles of SIRT6 in a multitude of biolog-
ical processes like cell proliferation, genome maintenance,
and transcriptional regulation, identification of lamin A as its
endogenous activator can have a profound impact on our under-
standing of the importance of lamin A-mediated regulation of
SIRT6 activities in a variety of physiological and pathological pro-
cesses, including metabolic diseases and tumorigenesis. In
addition, it provides prospective research directions in eluci-
dating molecular mechanisms underlying laminopathy-based
premature aging and in developing effective therapeutic strategy
for HGPS.
EXPERIMENTAL PROCEDURES
Cell Lines, Constructs, Recombinant Proteins, Reagents, and
Antibodies
Information regarding cell lines, constructs, recombinant proteins and anti-
bodies can be found in Supplemental Experimental Procedures.
Whole-Cell Lysate Collection, Western Blotting, and
Co-immunoprecipitation
Detailed procedures used for transfection, whole-cell lysate extraction, west-
ern blotting, and co-immunoprecipitation can be found in the Supplemental
Experimental Procedures.
Immunofluorescence Staining
Detailed procedures used for immunofluorescence staining can be found in
Supplemental Experimental Procedures.
Acid Extraction of Histones
Histones were extractedwith 0.2 NHCl using the protocol fromAbcam. Briefly,
cells were harvested and washed with PBS containing sodium butyrate. Cells
were then resuspended in Triton extraction buffer (PBS supplemented with
0.5% Triton X-100 [v/v], 2 mM PMSF, 0.02% NaN3 [v/v]) and lysed on ice for
10 min followed by centrifugation at 4C. Cells were washed again with TEB
(Triton extraction buffer) and centrifuged, and the pellet was resuspended in
0.2 N HCl followed by overnight acid extraction at 4C. Samples werethors
centrifuged for 10 min at 4C, and supernatant containing the extracted his-
tones was removed and stored at 80C as aliquots.
Cellular Fractionation and Chromatin Purification
Cellular fractionation and chromatin purification were performed as described
in Drouet et al. (2005) and McCord et al. (2009) to obtain stringent chromatin
extraction. Detailed procedures are provided in Supplemental Experimental
Procedures.
In Vitro SIRT6 Deacetylation Assay
SIRT6 deacetylase activity was assayed on its endogenous substrate (histone
H3) using the assay buffer as described in the SIRT6 direct fluorescent
screening assay kit (Cayman Chemical). Purified acetyl histones were incu-
bated with recombinant human SIRT6 (rhSIRT6) and NAD+ for 45 min at
37C, in the presence or absence of recombinant lamin A (rhlamin A), recom-
binant progerin (rhprogerin), or nicotinamide. Acetylation levels of histone H3
at lysine 9 and 56 were detected using antibodies against H3K9Ac (Millipore)
and H3K56Ac (Upstate).
Comet Assay
The neutral comet assay was performed as previously described in Olive and
Bana´th (2006). Detailed procedures are provided in Supplemental Experi-
mental Procedures.
Statistical Analysis
Statistical significance was analyzed using two-tailed t tests with error bars
representing SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.10.006.
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